Evidence map›Paper›PMID 27439953›Full record

ArticleAngewandte Chemie (International ed. in English)2016

A Modular Method for the High-Yield Synthesis of Site-Specific Protein-Polymer Therapeutics.

Yan Pang, Jinyao Liu, Yizhi Qi, Xinghai Li, Ashutosh Chilkoti

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Chemical Approaches to Synthetic Drug Delivery Systems for Systemic Applications.Angewandte Chemie (International ed. in English) · 2022
    Review
  5. Exploring the Potential of β-CateninMolecules (Basel, Switzerland) · 2020
    Article
  6. Article
  7. Review
  8. Genetically Encoded Cholesterol-Modified Polypeptides.Journal of the American Chemical Society · 2019
    Article
  9. Review
  10. Boosting Antitumor Drug Efficacy with Chemically Engineered Multidomain Proteins.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2018
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yan PangDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.
Jinyao LiuDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.
Yizhi QiDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.
Xinghai LiDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.
Ashutosh ChilkotiDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA. chilkoti@duke.edu.

Funding

Site-Specific Growth of Stealth Polymer from Peptide TherapeuticsR01DK092665 · NIDDK · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2011 to 2014
$1.3M
NIDDK NIH HHS R01 DK092665
6 · The paper itself

Abstract

A versatile method is described to engineer precisely defined protein/peptide-polymer therapeutics by a modular approach that consists of three steps: 1) fusion of a protein/peptide of interest with an elastin-like polypeptide that enables facile purification and high yields; 2) installation of a clickable group at the C terminus of the recombinant protein/peptide with almost complete conversion by enzyme-mediated ligation; and 3) attachment of a polymer by a click reaction with near-quantitative conversion. We demonstrate that this modular approach is applicable to various protein/peptide drugs and used it to conjugate them to structurally diverse water-soluble polymers that prolong the plasma circulation duration of these proteins. The protein/peptide-polymer conjugates exhibited significantly improved pharmacokinetics and therapeutic effects over the native protein/peptide upon administration to mice. The studies reported here provide a facile method for the synthesis of protein/peptide-polymer conjugates for therapeutic use and other applications.

Indexed as

Green Fluorescent ProteinsMolecular StructurePeptidesPolyethylene GlycolsGreen Fluorescent ProteinsPeptidesPolyethylene Glycolsclick chemistrydiabetespharmacokineticsprodrugsprotein modification

Identifiers

PMID27439953
PMCPMC5320947

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.